Ads
-
Related paper
- Interferon Treatment Improves Survival among Liver Transplant Recipients with Recurrent Hepatitis C
- Utilization of the Charlson Comorbidity Score to Predict 10-Year Survival in Renal Transplant Recipients
- Helicobacter Pylori Status in Explant Livers of Liver Transplant Recipients in a European Patient Cohort
- Fatal Multidrug-Resistant Klebsiella pneumonia Sepsis Episodes in Eight Liver Transplant Recipients |Biomedgrid
- The Impact of Hepatitis C Virus Infection on the Clinical Course, Short Term and Long–Term Outcome in Renal Transplant Recipients–A Prospective and Retrospective Study
- Management of Recurrent Hepatocellular Carcinoma after Liver Transplant - A Single Center Experience
- Vitiligo Associated With Pegylated Interferon and Ribavirin Treatment of Patients With Chronic Hepatitis C
- Pegylated Interferon Alfa 2a Treatment in Patients with Chronic Hepatitis B and Genotype D in Jordan
- Therapeutic Response of Black Africans in the Treatment of Genotype 2 Chronic Viral Hepatitis c by Pegylated Interferon-ribavirin
- Serum Anti-Interferon Alpha Antibodies in Chronic Hepatitis C Patients Treated with Pegylated Interferon Alpha Containing Therapy